About Us

We cordially invite you to participate in the International conference on Cardiology and Hypertension which will be held as in-person during February 21-22, 2022 in Paris, France. The main theme of Cardiology Meeting 2022 is “Challenges and Therapeutics Advances in Cardiology and Cardiovascular Disorders”.

Cardiology Meeting 2022 will focus on most recent advancements in all aspects of Cardiology. In this meeting Experts and Innovators from around the world will share knowledge, exam current therapies, and explore new ways to advance care for the unborn, neonates, adolescents and adults with cardiovascular disease. We have planned collaborative sessions for all disciplines along with special sessions for nursing, healthcare administrators and allied health professionals.

Scientific Session

Session 1: Cardiovascular Diseases & Heart Failure

The term cardiovascular disease is regularly replaceable with the expression "cardiovascular disease." Cardiovascular disease generally refers to conditions that incorporate constricted or blocked veins that can rapid a heart attack, chest pain (angina) or heart stroke. Other heart conditions, for instance, those that impact your heart's muscle, valves or beat, are considered forms of heart disease.

Heart failure, sometimes known as congestive heart failure, occurs when your heart muscle doesn't pump blood. Certain conditions, for instance, narrowed arteries in your heart (coronary artery disease or hypertension, progressively leave your heart excessively fragile or firm to fill and pump productively. There are two fundamental sorts of heart failure: heart failure due to left ventricular dysfunction and heart failure with normal ejection fraction. Simple reasons for heart failure incorporate coronary artery disease including a past myocardial infarction (heart attack), hypertension, atrial fibrillation, vascular heart disease, excess alcohol use, infection, and cardiomyopathy of an unknown cause.

Session 2: Cardiovascular Pharmacology and Therapeutics

Cardiac arrhythmias are any abnormality or perturbation in the ordinary initiation sequence of the myocardium. The sinus node, showing properties of automaticity, suddenly depolarizes, sending a depolarization wave over the atriium chamber, depolarizing the atrioventricular (AV) node, propagating over the His-Purkinje framework, and depolarizing the ventricle in systemic fashion. The normal rhythm of the heart, so-called normal sinus rhythm, can be aggravated through failure of automaticity, for example, sick sinus disorder, or through overactivity, for example, improper sinus tachycardia. Ectopic foci rashly energizing the myocardium on a single or continuous basis results in untimely premature atrial contractions (PACs) and premature ventricular contractions (PVCs). Sustained tachyarrhythmia in the atria, for example, atrial fibrillation, paroxysmal atrial tachycardia (PAT), and supraventricular tachycardia (SVT), begin due to smaller scale or large scale reentry.

Session 3: Clinical Cardiology

This aims to empower medical graduates who are already working or intending to work in cardiology topics of medical clinics with more profound comprehension of cardiology topics and furthermore broad specialists who wish to improve their insight and abilities in overseeing patients with cardiovascular conditions. The field incorporates medicinal determination and treatment of congenital heart defects, coronary artery disease, heart failure, valvular heart disease and electrophysiology.

Session 4: Cardiac Surgery and Transplantation

The improvement of cardiac surgery and cardiopulmonary sidestep procedures has lessened the death rates of these surgeries to generally low positions. Cardiac surgery, or cardiovascular surgery, is surgery performed on the heart or blood vessels by cardiac surgeons. For example, repairs of inborn heart deformities are at present assessed to have 4–6% death rates. It is often used to treat complications of ischemic heart diseases like coronary artery bypass grafting, to correct congenital heart disease; or to treat valvular heart disease from various causes, including endocarditis, rheumatic heart disease, and atherosclerosis. There will be expanded discussions regarding the new advanced technologies in cardiac transplantation and surgery processes.

Session 5: Cardiac Nursing

An advanced nurse practitioner practices autonomously within his/her expanded scope of clinical practice. The advanced nurse practitioner demonstrates highly developed assessment, diagnostic, analytical and clinical judgment skills and the components of this level of practice. This framework provides the foundation on which all future advanced practice roles are to be developed and existing roles are to be reviewed and subsequently managed. The framework is aimed at employers, service leads, education providers and senior or advanced practitioners themselves.

Cardiac surgery essentials for critical care nursing are the newest resource available to nurses who care for cardiac surgery patients. The goal of the cardiology conference was organized to make it useful to all nurses from novices to experts and to make the content specific to the cardiac surgery population rather than including all cardiothoracic procedures.

Session 6: Hypertension & Sports Cardiology

Hypertension, additionally called high blood pressure is a long term medical in which the blood pressure in the arteries is as often elevated. Hypertension usually does not cause side effects. Long term hypertension is a principle risk factor for coronary artery disease, stroke, heart failure, peripheral vascular disease, vision loss, and chronic kidney disease. It is classified as either essential (basic) hypertension or secondary high blood pressure. Sports Cardiology accomplishes heart screenings that distinguish potentially serious cardiovascular issues in young athletes. Sudden cardiac arrest (SCA) is the significant reason of death in exercising young athletes, and is most usually set off by issues—as structural heart disorders or electrical circuitry issues—which are not commonly found during routine physical examinations.

Session 7: Cardiovascular Drugs

The 10 drugs we're profiling here represent the largest in the market by worldwide 2016 deals, barring those that confronted conventional challenge consistently. We included medications that kept their exclusivity into a year ago, for example, AstraZeneca's Crestor, which confronted generics starting at July. In any case, But we left out brands that went generic prior to January 1, 2016, including Pfizer's Lipitor, which is as yet getting blockbuster marked deals—$1.75 billion a year ago, to be definite. Every one of the business numbers are obligingness of Evaluate Pharma, which ran its restrictive analysis for us in August 2017.

Session 8: Silent Ischemia and Ischemic Heart Disease

Many Americans may have ischemic episodes without knowing it. These people have ischemia without pain — silent ischemia. They may have a heart attack with no prior warning. People with angina also may have undiagnosed episodes of silent ischemia. In addition, people who have had previous heart attacks or those with diabetes are especially at risk for developing silent ischemia. Having an exercise stress test or wearing a Holter monitor – a battery-operated portable tape recording that measures and records your electrocardiogram (ECG) continuously, usually for 24-48 hours – are two tests often used to diagnose this problem.

Session 9: Cardiac Arrhythmias and Device Therapy

Cardiac arrhythmias are any abnormality or perturbation in the normal activation sequence of the myocardium. The sinus node, displaying properties of automaticity, spontaneously depolarizes, sending a depolarization wave over the atrium, depolarizing the atrio-ventricular (AV) node, propagating over the His-Purkinje system, and depolarizing the ventricle in systematic fashion. There are hundreds of different types of cardiac arrhythmias. The normal rhythm of the heart, so-called normal sinus rhythm, can be disturbed through failure of automaticity, such as sick sinus syndrome, or through overactivity, such as inappropriate sinus tachycardia. In general, the seriousness of cardiac arrhythmias depends on the presence or absence of structural heart disease.

Session 10: Personalized Medicine-The Future

Personalized Medicine helps these gatherings to shape the future of medicine by providing a platform for expert commentary and analysis. Personalized medicine is a novel therapeutic model with all decisions and practices being custom-made to individual patients in the ways imaginable. Also, when utilized in patient treatment, personalized medicine is regularly utilized in hazard counteractive action (54 percent), genetic testing (53 percent) and lifestyle change (50 percent). Therefore personalized treatment can be adjusted to reduce the cost of medication. Personalized medicine is probably going to change the essence of cardiovascular treatment in the near future.

Session 11: Interventional Cardiology

Interventional cardiology is a part of cardiology that deals with the catheter based treatment of structural heart diseases. Interventional cardiology is a non-surgical option which utilizes a catheter – a small, flexible tube – to repair damaged or weakened vessels, narrowed arteries, or other affected parts of the heart structure. An expansive number of methodologies can be performed on the heart by catheterization. The principle favorable circumstances of utilizing the interventional cardiology or radiology approach are the avoidance of the scars and pain, and long post-agent recovery. Moreover, interventional cardiology system of essential angioplasty is presently the highest quality level of consideration for an acute myocardial infarction.

Session 12: Myocardial Infarction

The most common symptom is chest pain or discomfort which may travel into the shoulder, arm, back, neck, or jaw. Often it occurs in the center or left side of the chest and lasts for more than a few minutes. Other symptoms may include shortness of breath, nausea, feeling faint, a cold sweat, or feeling tired. A Myocardial Infarction may cause heart failure, an irregular heartbeat, cardiogenic shock, or cardiac arrest.

Session 13: Pediatric and Geriatric Cardiology

Branch of medicine concerning youth heart issues is known as pediatric cardiology. Proper nursing and care for such kids is essential in addition to the treatments. They work intimately with a wide scope of experts as a feature of a multidisciplinary group to evaluate and treat patients. The developing field of geriatric cardiology reflects a shift in clinical practice as the typical cardiovascular (CV) patient is presently a lot more established than in the past with particular objectives and complexities identified with age. Cardiac disorders are principle reason of dismalness and mortality in elders. Proper nursing and care is essential.

Session 14: Live Supporting Cardiac Devices

Cardiovascular devices are used to treat and diagnose heart disorders. In the United States, heart diseases and strokes are the first and fifth most prevalent causes of death, respectively. According to a 2015 report from the American Heart Association, about 85.6 million people in the US suffer from cardiovascular diseases (or CVD). Major drivers for the US cardiovascular device segment are an aging population, unhealthy lifestyle trends, and increasing demand for minimally invasive surgeries. Cardiac rhythm management devices, interventional cardiac devices, and cardiac prosthetic devices are the major categories of cardiovascular devices.

Market Analysis

Market Analysis Report on Cardiology:

The global market for interventional cardiology technologies reached an estimated $12.2 billion in 2014. According to a new study by Smithers Apex â€“ The Future of Coronary Artery Disease Medical Devices to 2021 â€“ it will grow to $22.5 billion (â‚¬20.9 billion) by 2021, with a year-on-year increase of 9.1%. Demand for coronary artery disease medical devices will grow through 2021 as clinically viable and cost-effective solutions are developed.

The global interventional cardiology market is anticipated to grow at a steady rate and will post a CAGR of more than 7% during the forecast period. The growing demand for minimally invasive (MI) procedures will drive the growth prospects for the global interventional cardiology market in the forthcoming years. Some of the major factors responsible for the growing preference for MI include faster recovery, less pain, fewer post-surgery infections, reduced hospital stays, minimized incision marks, controlled bleeding, and minimal complications and high accuracy. Also, MI artery stenting enhances the surgical precision by providing a 3D view of the patient and allowing the manipulation of small surgical tools for the placement of stents in the individual's body. As a result, 3D-MRI techniques for improved imaging have increased the popularity of MRI procedures, which will eventually increase the demand for cardiac surgeries.

Smithers Apexâ€™s exclusive primary research and market data identifies three key trends that are driving the attractive evolution in the interventional cardiology technologies market.

Famous Renowned Medical Associations throughout the world:

American College of Cardiology, USA
American Heart Association, USA
European Society of Cardiology, France
Heart Rhythm Society, USA
Canadian Cardiovascular Society, Canada
National Heart Foundation of Australia, Australia
Indian Heart Association, India
Emirates Cardiac Society, UAE

Global Universities Offering Cardiology Education

Harvard University, USA
University of Oxford, USA
University of Cambridge, USA
Johns Hopkins University, USA
Stanford University, USA
Erasmus University Rotterdam, Netherlands
RWTH Aachen University, Germany
University of Groningen, Netherlands
The University of Edinburgh, Scotland
University of Copenhagen, Denmark
National University of Singapore, Singapore
Tsinghua University, China
Peking University, China
University of Hong Kong, Hong Kong
Hong Kong University of Science and Technology, Hong Kong
Istanbul University, Turkey
King Saud University, Saudi Arabia
Cairo University, Egypt
American University of Beirut, Lebanon

Global Hospitals Leading Cardiac Research

Cleveland Clinic, USA
New York-Presbyterian Hospital-Columbia and Cornell, USA
Mayo Clinic, USA
Cedars-Sinai Medical Center, USA
Massachusetts General Hospital, USA
Grupo Hospitalario Quiron, Spain
American Heart of Poland, Poland
SARAFIANOS Private Clinic, Greece
Hospital Ruber Internacional, Spain
Hygeia Hospital, Greece
Mahkota Medical Centre, Malaysia
Bangkok Hospital Pattaya, Thailand
Fortis Escorts Heart Institute, India
Gleneagles Intan Medical Centre, Malaysia
Sunway Medical Centre, Malaysia
Rambam Medical Center, Israel
Specialty Hospital, Jordan
Anadolu Medical Center, Turkey
Medicine Healthcare Group, Turkey
Istanbul Memorial Hospital, Turkey

Global Funding Bodies

American Heart Association
American Society of Preventive Cardiology
European Society of Cardiology
Association for European Paediatric Cardiology
Gulf Heart Association
The Singapore Cardiac Society
National Heart Association of Malaysia
Emirates Cardiac Society
Israel Heart Society

Young Scientist Award

Meetings International is announcing Young Scientist Awards through “International conference on Cardiology and Hypertension” (Cardiology 2022) which is scheduled in Paris, France during February 21-22, 2022. This Cardiology 2022 focuses on “Progresses in Cardiology: Research and Innovations”.

Cardiology 2022 and upcoming conferences will recognize participants who have significantly added value to the scientific community of critical care and provide them outstanding Young Scientist Awards. The Young Scientist Award will provide a strong professional development opportunity for young researches by meeting experts to exchange and share their experiences at our international conferences.

Cardiology 2022 aims on the level of thought that individual patients need at various centers in their course. Clinical decision guidelines are generally perceived as best practice for an inexorably normal nearness in the biomedical composition. Cardiology and Hypertension conference conference is providing a platform for all the budding young researchers, young investigators, post-graduate/Master students, PhD. students and trainees to showcase their research and innovation.

Eligibility:
Young Scientists, faculty members, post-doctoral fellows, PhD scholars and bright Final Year MSc and M.Phil. Candidates. Persons from Scientific Industry can also participate.

Benefits:

The Young Scientist Feature is a platform to promote young researchers in their respective area by giving them a chance to present their achievements and future perspectives.
Acknowledgement as YRF Awardee
Promotion on the conference website, Young Researcher Awards and certificates
Link on the conference website
Recognition on Meetings Int. Award Page
Chances to coordinate with partners around the world
Research work can be published in the relevant journal without any publication fee

Criteria:

All presented abstracts will automatically be considered for the Award.
All the presentation will be evaluated in the conference venue
All the awards will be selected by the judges of the award category
The winners of the Young Scientist Award will receive award certificate.
The awards will be assessed as far as plan and format, intelligence, argumentation and approach, familiarity with past work, engaging quality, message and primary concerns, parity of content visuals, and by and large impression.

Guidelines:

All submissions must be in English.
The topic must fit into scientific sessions of the conference
Each individual participant is allowed to submit maximum 2 papers
Abstract must be submitted online as per the given abstract template
Abstracts must be written in Times New Roman and font size will be 12
Abstract must contain title, name, affiliation, country, speakers biography, recent photograph, image and reference.

Conditions of Acceptance:
To receive the award, the awardee must submit the presentation for which the award is given, for publication at the website, along with author permission. Failure to submit the PPT and permission within the designated timeframe will result in forfeiture of award.

Award Announcements:
Official announcement of the recipients will occur after the completion of Cardiology Conference.

Be a part of 11^th International Conference on Cardiology and Hypertension

About Us

Date

Location

Download

Submit

Program

About Us

Scientific Session

Market Analysis

Young Scientist Award

Recommended Conferences

2nd International conference On Cardiology

Be a part of 11th International Conference on Cardiology and Hypertension

About Us

Date

Location

Download

Submit

Program

About Us

Scientific Session

Market Analysis

Young Scientist Award

Recommended Conferences

2nd International conference On Cardiology

Our Supporters

Be a part of 11^th International Conference on Cardiology and Hypertension